AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
CytRx Corp. announces agreement with Sands Brothers.
2002 NOV 20 - (NewsRx.com & NewsRx.net) -- CytRx Corp. (NASDAQ:CYTR) announced its board of directors has approved the hiring of Sands Brothers & Company, Ltd., through an Investment Banking Agreement focusing on potential strategic alliances, mergers, and acquisition matters and corporate finance.
CytRx's new relationship with Sands Brothers may provide CytRx with much needed sponsorship in the Nasdaq Small Cap arena. Sands Brothers and its affiliates employ a staff of over 500 professionals, with offices in New York, London, California, Florida, Texas, and Colorado.
CytRx Corporation is a biopharmaceutical company focused on the development and commercialization of high-value human therapeutics. The company's current portfolio of products under development includes Flocor, an intravenous agent for treatment of sickle cell disease and other acute vaso-occlusive disorders, and TranzFect, a delivery technology for DNA-based vaccines. CytRx has licensed TranzFect to Merck & Co., Inc., for use in Merck's efforts to develop DNA-based vaccines for HIV and three other infectious diseases.
A number of other uses of TranzFect for enhancement of viral or nonviral delivery of polynucleotides (such as DNA and RNA) have been licensed to Vical, Inc.
CytRx has a research pipeline in the areas of muscular ...
- CytRx Corporation Announces Investment Banking Agreement With Sands Brothers.
- Press release article from: PR Newswire October 8, 2002 700+ words
...and corporate finance. CytRx's new relationship with Sands Brothers may provide CytRx with much needed sponsorship...Investment Banking with Sands Brothers & Company, Ltd., stated, "We believe CytRx possesses a valuable...
- CytRx Corp. announces agreement with Sands Brothers.
- Newspaper article from: Gene Therapy Weekly November 21, 2002 700+ words
...and corporate finance. CytRx's new relationship with Sands Brothers may provide CytRx with much needed sponsorship...capacity." Andrew Scott, Sands Brothers & Company, Ltd., stated, "We believe CytRx possesses a valuable...
- CytRx Transformation Completed as it Focuses On RNAi Technology and HIV Program.
- Press release article from: PR Newswire January 16, 2004 700+ words
...RNAi technology and DNA-based vaccines, CytRx Corporation announced today that it will...indications. This event will have no effect on CytRx's cash or working capital position. In the past nine months, CytRx has invested more than $3.7 million...
- CytRx to Present at Rodman and Renshaw Techvest Annual Healthcare Conference.
- Press release article from: PR Newswire October 13, 2004 700+ words
...Steven Kriegsman, President and CEO of CytRx Corporation will present at the Rodman...Starlight Roof Center in New York City. CytRx is one of 241 invited companies to present...presentation, Mr. Kriegsman will discuss CytRx's recent acquisition of Biorex Research...
- CytRx CEO Featured in Current Issue of RNAi News; - Steven A. Kriegsman...
- Press release article from: PR Newswire November 12, 2003 700+ words
...silencing") features an interview with CytRx Corporation Chief Executive Officer Steven...current issue. The story, headlined, "CytRx's Steven Kriegsman Discusses the Company's Foray into RNAi," discusses how CytRx moved into RNAi as its primary strategic...
- CytRx CEO to Discuss Business Strategy at Westergaard SmallCap Conference.
- Press release article from: PR Newswire October 28, 2003 700+ words
Steven A. Kriegsman, CEO of CytRx Corporation , will present at the 26th...his presentation, Kriegsman will discuss CytRx's business strategy, which focuses on...market medical needs, and the steps CytRx has taken recently to implement that strategy...
- CytRx Appoints Jack R. Barber, Ph.D. Senior Vice President of Drug Development.
- Press release article from: PR Newswire July 22, 2004 700+ words
CytRx Corporation has appointed Jack R. Barber...Barber will report to Steven A. Kriegsman, CytRx President and Chief Executive Officer...biomedical research experience that uniquely fits CytRx's commercial objectives. Jack's keen...
- CytRx Announces Tax Value of Distributed Shares of RXi Common Stock.
- Press release article from: Business Wire May 7, 2008 700+ words
LOS ANGELES -- CytRx Corporation (NASDAQ:CYTR), a biopharmaceutical...Corporation (NASDAQ:RXII) distributed to CytRx stockholders on March 11, 2008 at $8...companies. As previously reported, each CytRx stockholder who received RXi shares is...
